Clicky

Phathom Pharmaceuticals, Inc.(PHAT)

Description: Phathom Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development and commercialization of novel treatments for gastrointestinal diseases and disorders. It develops Vonoprazan, a potassium-competitive acid blocker. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Buffalo Grove, IL.


Keywords: Natural Sciences Biopharmaceutical Life Sciences Medication Acid Disorders Potassium Gastrointestinal Gastrointestinal Disease Tadataka Yamada

Home Page: www.phathompharma.com

PHAT Technical Analysis

100 Campus Drive
Florham Park, NJ 07932
United States
Phone: 877 742 8466


Officers

Name Title
Ms. Terrie J. Curran Pres, CEO & Director
Mr. David A. Socks Co-Founder & Director
Dr. Azmi Nabulsi M.D., M.P.H. Co-Founder & COO
Mr. Anthony J. Guzzo Chief Accounting Officer
Mr. Aditya Kohli Ph.D. Co-Founder
Ms. Molly Henderson CPA, MBA Chief Financial & Bus. Officer
Mr. Joseph Hand J.D. Chief Admin. Officer
Mr. Lawrence Miller Esq., J.D. Gen. Counsel & Sec.
Mr. Tom Harris Chief Devel. Sciences Officer
Dr. Eckhard Leifke M.D., Ph.D. Chief Medical Officer

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 6.6361
Price-to-Sales TTM: 0
IPO Date: 2019-10-25
Fiscal Year End: December
Full Time Employees: 77
Back to stocks